Bio-Rad Laboratories Financial Ratios
BIO / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
10.2%
ROE ranks in the above average among Health Care companies
Profit Margin
29.4%
Net Income / Revenue
Asset Turnover
0.24
Revenue / Total Assets
Equity Multiplier
1.42
Total Assets / Equity
Composite: 10.2% (reported: 10.2%)
Profitability
Liquidity
Current Ratio
5.62
Quick Ratio
4.19
Solvency
Interest Coverage
10.86
Efficiency
Asset Turnover
0.24
Inventory Turnover
1.68
Days Sales Outstanding
65 days
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Earnings Quality
Accrual Ratio
+2.3%
+26.8pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.